Clinical trial
Investigation of the Lymphocyte Surface Expression of Patients With Primary Immunodeficiency (Common Variable Immunodeficiency (CVID)), Compared to Controls
NCT01196702 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Lymphocyte Surface Expression of Patients With Primary Immunodeficiency (Common Variable Immunodeficiency (CVID)), Compared to Controls
- Lead sponsor
- Barts & The London NHS Trust
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2020
- Completion date
- December 30, 2023
- Enrollment
- 210 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchiectasis, common variable immunodeficiency, granulomatous disease, immunoglobulin treatment